NGeneBio Co., Ltd. (KOSDAQ: 354200)
South Korea
· Delayed Price · Currency is KRW
1,683.00
+27.00 (1.63%)
Jan 22, 2025, 3:00 PM KST
NGeneBio Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Jan '25 Jan 21, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 33,355 | 71,664 | 116,027 | 201,381 |
| Market Cap Growth | -36.82% | -38.23% | -42.38% | - |
| Enterprise Value | 41,698 | 56,797 | 89,239 | - |
| Last Close Price | 1683.00 | 5248.14 | 8759.48 | 15291.34 |
| PS Ratio | 3.51 | 16.47 | 10.53 | 28.11 |
| PB Ratio | 2.50 | 4.41 | 4.58 | 5.92 |
| P/TBV Ratio | 31.02 | 4.97 | 4.90 | 6.23 |
| EV/Sales Ratio | 6.75 | 13.05 | 8.10 | - |
| Debt / Equity Ratio | 1.36 | 0.70 | 0.45 | 0.21 |
| Asset Turnover | 0.15 | 0.09 | 0.22 | - |
| Inventory Turnover | 1.77 | 1.93 | 3.29 | - |
| Quick Ratio | 0.44 | 0.98 | 1.24 | 3.22 |
| Current Ratio | 0.57 | 1.13 | 1.49 | 3.40 |
| Return on Equity (ROE) | -89.89% | -61.88% | -33.17% | - |
| Return on Assets (ROA) | -22.61% | -17.05% | -10.75% | - |
| Return on Capital (ROIC) | -36.48% | -26.03% | -13.78% | - |
| Earnings Yield | -70.64% | -17.82% | -8.43% | -4.19% |
| FCF Yield | -44.26% | -13.33% | -7.63% | -5.24% |
| Buyback Yield / Dilution | -2.40% | -1.66% | -0.89% | - |
| Total Shareholder Return | -2.40% | -1.66% | -0.89% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.